Shares in Moderna came under pressure on Friday, after fourth-quarter losses at the US biotech were bigger than expected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback